{"version":"1.0","provider_name":"Regulatory Affairs - Life Sciences","provider_url":"https:\/\/maxregconsult.com\/en","author_name":"Oskar","author_url":"https:\/\/maxregconsult.com\/en\/author\/oskar\/","title":"Farmakovigilans","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XQjnMoLFnN\"><a href=\"https:\/\/maxregconsult.com\/en\/tjanster\/farmakovigilans\/\">Pharmacovigilance<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/maxregconsult.com\/en\/tjanster\/farmakovigilans\/embed\/#?secret=XQjnMoLFnN\" width=\"600\" height=\"338\" title=\"&#8220;Farmakovigilans&#8221; &#8212; Regulatory Affairs - Life Sciences\" data-secret=\"XQjnMoLFnN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/maxregconsult.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"Farmakovigilans (PV) S\u00e4kerhets\u00f6vervakning och rapportering f\u00f6r l\u00e4kemedel inom Norden och EU. Om tj\u00e4nsten Farmakovigilans (PV) MAx RegConsult erbjuder kvalificerat st\u00f6d inom farmakovigilans \u2013 fr\u00e5n systemuppbyggnad och signalhantering till rapportering och revision.Vi hj\u00e4lper Life Science-f\u00f6retag att uppfylla myndighetskraven och s\u00e4kra patients\u00e4kerhet genom hela produktens livscykel \u2013 med fokus p\u00e5 noggrannhet, struktur och trygghet. Signalhantering &amp; case [&hellip;]","thumbnail_url":"https:\/\/maxregconsult.com\/wp-content\/uploads\/2025\/11\/0f5de010-ed14-4bb2-9dc4-efa5ff52dde3.png"}